{
  "report_rows": [
    {
      "kpi": "Q4 FY2026 Core EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.43 vs. cons $1.407",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q4 FY2026 Organic Sales Growth",
      "prediction": "MISS",
      "answer": "pred ~+1.0% vs. cons +1.62%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2027 Core EPS (first guidance)",
      "prediction": "MISS",
      "answer": "pred ~$6.90 mid vs. cons $7.00",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2027 Core EPS (FY2027)",
      "prediction": "LOWER",
      "answer": "guide ~$6.80-$7.00 mid $6.90 vs. cons $7.00",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2027 Organic Sales Growth (FY2027)",
      "prediction": "BETTER",
      "answer": "guide ~+2%-+4% mid ~+3% vs. cons +2.5%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 Full-Year Core EPS (FY2026)",
      "prediction": "UNCHANGED",
      "answer": "narrow to $6.83-$6.90, in-line with cons $6.88",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": -2.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -3.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 sell-side FY2027 EPS cuts ($7.00 to ~$6.90) extend the move; no catalyst to reverse in 5 days",
  "day5_confidence": "MEDIUM"
}